UHS — Universal Health Services, Inc.

Universal Health Services (UHS) Q3 2025 Earnings Call Summary

1. Key Financial Results and Metrics

• Adjusted Net Income: $5.69 per share, a 53% increase year-over-year.
• Revenue Growth: 13.4% year-over-year.
• Net Income: $5.86 per diluted share.
• Acute Care Admissions: Increased 2.0% year-over-year.
• Same-Facility Revenue: Acute care segment up 12.8% (9.4% excluding Medicaid benefits); Behavioral health up 9.3% (8.5% excluding Medicaid benefits).
• EBITDA Margin: Increased by 190 basis points to 15.8% for acute care.
• Operating Cash Flow: Approximately $1.3 billion for the first nine months of 2025.
• Capital Expenditures: $734 million year-to-date, with a focus on new facilities.

2. Strategic Updates and Business Highlights

• Medicaid Supplemental Program: $90 million benefit recognized from the District of Columbia program, contributing significantly to revenue.
• New Facilities: Progress reported at West Henderson Hospital and Cedar Hill Regional Medical Center, with Cedar Hill expected to break even by Q4 2025.
• Outpatient Strategy: Expansion of outpatient services, including 10 new step-in programs and a new wellness brand.
• Stock Repurchase Program: Increased authorization to $1.5 billion, emphasizing commitment to returning capital to shareholders.

3. Forward Guidance and Outlook

• Adjusted EPS Guidance: Increased midpoint for 2025 to $21.80 from $20.50, reflecting operational performance and Medicaid benefits.
• Volume Expectations: Anticipated same-facility adjusted patient day growth of 2% to 3% for behavioral health in Q4, with a focus on achieving the lower end of this range.
• Long-Term Growth: Targeting 2% to 3% volume growth in behavioral health and 5% to 6% revenue growth in acute care.

4. Bad News, Challenges, or Points of Concern

• Increased Liability Reserves: Additional reserves for professional and general liability have been established, impacting guidance.
• Labor Market Tightness: Continued challenges in staffing, particularly in behavioral health, affecting volume growth.
• Potential Medicaid Cuts: Future reductions in Medicaid revenues projected due to legislative changes, with an estimated annual impact of $420 million to $470 million starting in 2028.
• Cannibalization of Volumes: New facilities like West Henderson may cannibalize admissions from existing hospitals, slightly impacting overall volume metrics.

5. Notable Q&A Insights

• Medicaid Approvals: Potential benefits from pending Medicaid programs in Florida and Nevada could total $75 million to $80 million, pending CMS approval.
• Exchange Contribution: Exchange patients now represent 6% to 6.5% of total admissions, with expectations of a $50 million to $100 million negative impact if subsidies expire.
• Surgical Volume Trends: Slight improvement noted in outpatient surgical volumes, with cardiology services performing particularly well.
• Competitive Dynamics: UHS remains cautious about competitor behaviors in the behavioral health space, noting that some competitors are reducing capacity, potentially easing market pressures.

This summary encapsulates the key points from UHS's Q3 2025 earnings call, highlighting financial performance, strategic initiatives, and challenges faced by the company.